ABP 501, Adalimumab Biosimilar, Safe and Effective, for Psoriasis
Findings based on comparison over 52 weeks, including single transition
Canagliflozin Delays Increase in Certain CV Biomarkers in T2DM
Canagliflozin may reduce CV, heart failure risk over two years versus placebo in older patients with T2DM
Similar Defects ID’d for T2DM, Chronic Pancreatitis and Diabetes
Similarly disturbed α-cell responses to oral glucose ingestion and hypoglycemia
Diabetes Symptoms Appear to Spread Via Prion-Like Mechanism
Injections in mice led to symptoms of the disease, researchers report
Little Risk of Oropharyngeal Mucosal Transmission of Zika
Research with monkeys suggests virus isn't transmitted through kissing, sharing eating utensils
U.S. Doctors Still Writing Too Many Opioid Prescriptions
Nearly 92 million Americans used legitimately prescribed opioids in 2015, survey shows
Periodontal Disease History Linked to Increased Cancer Risk
For older women, risk of total cancer, melanoma, and breast, lung, esophagus, gallbladder cancers up
Methylprednisolone Ups Adverse Events in IgA Nephropathy
Recruitment discontinued because of serious adverse events after randomization of 262 patients
Climate Change Expected to Up Premature Deaths From Pollution
Premature mortality attributable to climate change estimated to be greatest in India, East Asia
New Research Supports Safety of Aspirin in Heart Failure
Large trial comparing it to warfarin finds aspirin not tied to more hospitalizations or deaths
